Derivation of multipotent progenitors from human circulating CD14+ monocytes

Experimental Hematology

Volumn 38, Issue 7, 2010, Pages 557-563

  Seta, Noriyuki ^a   Kuwana, Masataka ^a  

^a KEIO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CD14 ANTIGEN; CD34 ANTIGEN; CD45 ANTIGEN; COLLAGEN TYPE 1; FIBRONECTIN; HEMOPOIETIC GROWTH FACTOR; OCTAMER TRANSCRIPTION FACTOR 4; TRANSCRIPTION FACTOR NANOG;

ADIPOCYTE; BONE CELL; CARTILAGE CELL; CELL CONTACT; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; FIBROBLAST CULTURE; GENE EXPRESSION PROFILING; HEART MUSCLE CELL; HEMATOPOIETIC STEM CELL; HUMAN; INNATE IMMUNITY; LYMPHOCYTE DIFFERENTIATION; LYMPHOCYTE SUBPOPULATION; MONOCYTE MACROPHAGE PRECURSOR CELL; MULTIPOTENT STEM CELL; MUSCLE CELL; NERVE CELL; NONHUMAN; PHAGOCYTE; PHENOTYPE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION; PROTEIN SECRETION; REVIEW; T LYMPHOCYTE ACTIVATION; TISSUE REGENERATION; TISSUE REPAIR;

ANTIGENS, CD14; CELL DIFFERENTIATION; HUMANS; MONOCYTES; MULTIPOTENT STEM CELLS;

EID: 77953543306     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2010.03.015     Document Type: Review

References (28)

1. Grove J.E., Bruscia E., Krause D.S. Plasticity of bone marrow-derived stem cells. Stem Cells 2004, 22:487-500.
2. Masuya M., Drake C.J., Fleming P.A., et al. Hematopoietic origin of glomerular mesangial cells. Blood 2003, 101:2215-2218.
3. Sera Y., LaRue A.C., Moussa O., et al. Hematopoietic stem cell origin of adipocytes. Exp Hematol 2009, 37:1108-1120.
4. Fujita J., Mori M., Kawada H., et al. Administration of granulocyte colony-stimulating factor after myocardial infarction enhances the recruitment of hematopoietic stem cell-derived myofibroblasts and contributes to cardiac repair. Stem Cells 2007, 25:2750-2759.
5. Miyamoto T., Ohneda O., Arai F., et al. Bifurcation of osteoclasts and dendritic cells from common progenitors. Blood 2001, 98:2544-2554.
6. + macrophage precursors commit sequentially to osteoclasts, dendritic cells and microglia. BMC Immunol 2002, 3:15-25.
7. Naito M., Hasegawa G., Takahashi K. Development, differentiation, and maturation of Kupffer cells. Microsc Res Tech 1997, 39:350-364.
8. Zhao Y., Glesne D., Huberman E., et al. A human peripheral blood monocyte-derived subset acts as pluripotent stem cells. Proc Natl Acad Sci U S A 2003, 100:2426-2431.
9. low cells with stem cell phenotypic and functional features are the major source of circulating endothelial progenitors. Circ Res 2005, 97:314-322.
10. + monocytes as a source of progenitors that exhibit mesenchymal cell differentiation. J Leukoc Biol 2003, 74:833-845.
11. Takeda Y., Mori T., Imabayashi H., et al. Can the life span of human marrow stromal cells be prolonged by bmi-1, E6, E7, and/or telomerase without affecting cardiomyogenic differentiation?. J Gene Med 2004, 6:833-845.
12. Pittenger M.F., Mackay A.M., Beck S.C., et al. Multilineage potential of adult human mesenchymal stem cells. Science 1999, 284:143-147.
13. + monocytes. Stem Cell Dev 2005, 14:676-686.
14. + monocytes. Immunol Cell Biol 2006, 84:209-217.
15. Kuwana M., Okazaki Y., Kodama H., Satoh T., Kawakami Y., Ikeda Y. Endothelial differentiation potential of human monocyte-derived multipotential cells. Stem Cells 2006, 24:2733-2743.
16. Seta N., Okazaki Y., Kuwana M. Human circulating monocytes can express receptor activator of nuclear factor-κB ligand and differentiate into functional osteoclasts without exogenous stimulation. Immunol Cell Biol 2008, 86:453-459.
17. Bucala R., Spiegel L.A., Chesney J., Hogan M., Cerami A. Circulating fibrocytes define a new leukocyte subpopulation that mediates tissue repair. Mol Med 1994, 1:71-81.
18. Strieter R.M., Gomperts B.N., Keane M.P. The role of CXC chemokines in pulmonary fibrosis. J Clin Invest 2007, 117:549-556.
19. + fibrocytes: morphology, histogenesis and function. Curr Stem Cell Res Ther 2007, 2:221-227.
20. Chambers I., Colby D., Robertson M., et al. Functional expression cloning of Nanog a pluripotency sustaining factor in embryonic stem cells. Cell 2003, 113:643-655.
21. Pesce M., Scholer H.R. Oct-4: gatekeeper in the beginnings of mammalian development. Stem Cells 2001, 19:271-278.
22. Makino K., Kuwahara H., Masuko N., et al. Cloning and characterization of NE-dlg: a novel human homolog of the Drosophila discs large (dlg) tumor suppressor protein interacts with the APC protein. Oncogene 1997, 14:2425-2453.
23. Bohil A.B., Robertson B.W., Cheney R.E. Myosin-X is a molecular motor that functions in filopodia formation. Proc Natl Acad Sci U S A 2006, 103:12411-12416.
24. Zhang H., Berg J.S., Li Z., et al. Myosin-X provides a motor-based link between integrins and the cytoskeleton. Nat Cell Biol 2004, 6:523-531.
25. Majumdar M.K., Thiede M.A., Haynesworth S.E., Bruder S.P., Gerson S.L. Human marrow-derived mesenchymal stem cells (MSCs) express hematopoietic cytokines and support long-term hematopoiesis when differentiated toward stromal and osteogenic lineages. J Hematother Stem Cell Res 2000, 9:841-848.
26. Kucher C., Xu X., Pasha T., Elenitsas R. Histopathologic comparison of nephrogenic fibrosing dermopathy and scleromyxedema. J Cutan Pathol 2005, 32:484-490.
27. Bardin T., Richette P. Nephrogenic systemic fibrosis. Curr Opin Rheumatol 2010, 22:54-58.
28. Mattoli S., Bellini A., Schmidt M. The role of a human hematopoietic mesenchymal progenitor in wound healing and fibrotic diseases and implications for therapy. Curr Stem Cell Res Ther 2009, 4:266-280.